Innovative ICDs Automatically Adapt to MRI Settings
By HospiMedica International staff writers Posted on 17 Feb 2016 |
A new line of implantable cardioverter defibrillators (ICDs) and cardiac resynchronization devices (CRT-Ds) can automatically detect MRI environments.
The Biotronik Ilivia ICDs and CRT-Ds feature both ProMRI, a technology that allows patients with a cardiac system to safely access MRI scanning, and MRI AutoDetect, which allows the cardiologist to activate a time window lasting up to 14 days, during which all device functionality is maintained until the patient undergoes the actual scan; at that point the device automatically switches into MRI mode. Once the scan is completed, all device functionality is once again restored automatically, all without the need for the cardiologist’s intervention.
Soon after the scan, the cardiologist receives a full report via Biotronik Home Monitoring, a system designed to replace device interrogation with customizable fully programmable alerts, with options to specify alert thresholds and ranges, and call-back notifications that direct the patient to contact the clinic. Other features include MultiPole Pacing (MPP) to improve therapy for CRT patients, a closed loop stimulation (CLS) algorithm for more adaptive pacing, and DX technology for ICDs and CRT-Ds. Biotronik Ilivia ICDs and CRT-Ds are products of Biotronik (Berlin, Germany).
“MRI AutoDetect will not only reduce the amount of time the patient’s device stays in MRI mode, but I expect it will also greatly improve the workflow between the cardiologist and radiologist, which will ultimately benefit our patients,” said Manuel Ortega, senior vice president of Biotronik. “MRI AutoDetect is the next step in ensuring that patients get the full benefit of both their implanted devices and diagnostic imaging.”
“Patients aren’t fully protected if they have an event while their devices are programmed in MRI mode, a period that currently can last a day or more depending on hospital workflows,” said Richard Kobza, MD, head of cardiology at Luzerner Kantonsspital (Lucerne, Switzerland). “Reducing the amount of time a device is in MRI mode is particularly crucial for ICD and CRT-D patients, and with MRI AutoDetect the only time these patients won’t be able to benefit from full device therapy is the short 30-minute window they spend in the MRI machine itself.”
At present, when a cardiac device patient needs to undergo a MRI scan, a cardiologist must program his or her device into a special mode that temporarily reduces the device’s functionality until the MRI scan is completed. Following the scan, the cardiologist must switch off the device’s MRI mode to allow the patient to once again have the full therapeutic benefits of their implanted device.
Related Links:
Biotronik
The Biotronik Ilivia ICDs and CRT-Ds feature both ProMRI, a technology that allows patients with a cardiac system to safely access MRI scanning, and MRI AutoDetect, which allows the cardiologist to activate a time window lasting up to 14 days, during which all device functionality is maintained until the patient undergoes the actual scan; at that point the device automatically switches into MRI mode. Once the scan is completed, all device functionality is once again restored automatically, all without the need for the cardiologist’s intervention.
Soon after the scan, the cardiologist receives a full report via Biotronik Home Monitoring, a system designed to replace device interrogation with customizable fully programmable alerts, with options to specify alert thresholds and ranges, and call-back notifications that direct the patient to contact the clinic. Other features include MultiPole Pacing (MPP) to improve therapy for CRT patients, a closed loop stimulation (CLS) algorithm for more adaptive pacing, and DX technology for ICDs and CRT-Ds. Biotronik Ilivia ICDs and CRT-Ds are products of Biotronik (Berlin, Germany).
“MRI AutoDetect will not only reduce the amount of time the patient’s device stays in MRI mode, but I expect it will also greatly improve the workflow between the cardiologist and radiologist, which will ultimately benefit our patients,” said Manuel Ortega, senior vice president of Biotronik. “MRI AutoDetect is the next step in ensuring that patients get the full benefit of both their implanted devices and diagnostic imaging.”
“Patients aren’t fully protected if they have an event while their devices are programmed in MRI mode, a period that currently can last a day or more depending on hospital workflows,” said Richard Kobza, MD, head of cardiology at Luzerner Kantonsspital (Lucerne, Switzerland). “Reducing the amount of time a device is in MRI mode is particularly crucial for ICD and CRT-D patients, and with MRI AutoDetect the only time these patients won’t be able to benefit from full device therapy is the short 30-minute window they spend in the MRI machine itself.”
At present, when a cardiac device patient needs to undergo a MRI scan, a cardiologist must program his or her device into a special mode that temporarily reduces the device’s functionality until the MRI scan is completed. Following the scan, the cardiologist must switch off the device’s MRI mode to allow the patient to once again have the full therapeutic benefits of their implanted device.
Related Links:
Biotronik
Read the full article by registering today, it's FREE!
Register now for FREE to HospiMedica.com and get complete access to news and events that shape the world of Hospital Medicine.
- Free digital version edition of HospiMedica International sent by email on regular basis
- Free print version of HospiMedica International magazine (available only outside USA and Canada).
- Free and unlimited access to back issues of HospiMedica International in digital format
- Free HospiMedica International Newsletter sent every week containing the latest news
- Free breaking news sent via email
- Free access to Events Calendar
- Free access to LinkXpress new product services
- REGISTRATION IS FREE AND EASY!
Sign in: Registered website members
Sign in: Registered magazine subscribers
Latest Critical Care News
- AI Doubles Medical Professionals’ Accuracy in Reading EEG Charts of ICU Patients
- Flexible Device Enables Sweat Gland Stimulation and Simultaneous Biosensing
- WHO Publishes First Global Guidelines to Reduce Bloodstream Infections from Catheter Use
- Innovative Material Paves Way for Next-Generation Wearable Devices
- Wireless Electronic Suture Enables Postoperative Long-Term Monitoring Of Soft Tissue
- Transcatheter Valve Replacement Outcomes Similar To Surgery, Finds Study
- Revascularization Improves Life Quality in Chronic Limb-Threatening Ischemia, Finds Study
- Powerful AI Risk Assessment Tool Predicts Outcomes in Heart Failure Patients
- Peptide-Based Hydrogels Repair Damaged Organs and Tissues On-The-Spot
- One-Hour Endoscopic Procedure Could Eliminate Need for Insulin for Type 2 Diabetes
- AI Can Prioritize Emergency Department Patients Requiring Urgent Treatment
- AI to Improve Diagnosis of Atrial Fibrillation
- Stretchable Microneedles to Help In Accurate Tracking of Abnormalities and Identifying Rapid Treatment
- Machine Learning Tool Identifies Rare, Undiagnosed Immune Disorders from Patient EHRs
- On-Skin Wearable Bioelectronic Device Paves Way for Intelligent Implants
- First-Of-Its-Kind Dissolvable Stent to Improve Outcomes for Patients with Severe PAD